Tmod cellular logic gate as a solution to on-target, off-tumor toxicity in CAR-T for solid tumors
J. Randolph Hecht • 15 Nov 2022
1L treatment in mesothelioma: optimizing treatments for individual patients
Wanda Cui • 7 Aug 2022
Which subtypes of patients with mesothelioma are most likely to benefit from immunotherapy?
Riyaz Shah • 8 Jul 2022